High prevalence of SDHB mutations in head and neck paraganglioma in Belgium
- 1 July 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 26 (7), 1395-1401
- https://doi.org/10.1097/hjh.0b013e3282ffdc54
Abstract
Background Recent reports have found genetic mutations in up to one quarter of patients harbouring pheochromocytoma and/or paraganglioma. This high prevalence was mainly due to the discovery of the role of SDH genes. While SDHD has been more frequently associated with the pathogenesis of head and neck paragangliomas, SDHB mutations were mainly associated with malignant and/or extra-adrenal pheochromocytoma/paraganglioma. Objective To look for mutations in susceptibility genes and genotype–phenotype correlations in patients with pheochromocytoma and/or paraganglioma from Belgium. Methods Screening of the coding parts of SDH, VHL and RET genes was performed by SSCP in patients with pheochromocytoma and/or paraganglioma diagnosed at or referred to the Cliniques Universitaires Saint Luc from May 2003 to May 2006. Results Fifty-six unrelated patients were included (36 head and neck paragangliomas, including six familial cases and 30 sporadic cases; 18 abdominal pheochromocytoma/paraganglioma and two paraganglioma of the cauda equina). The overall prevalence of mutations was 41% (n = 23 including 19 head and neck paragangliomas and four abdominal pheochromocytoma/paraganglioma), mainly due to SDH mutations. While SDHD mutations were found in all patients with familial head and neck paragangliomas, in sporadic cases, the prevalence of SDHB mutations (n = 8, 27%) was twice that of SDHD mutations (n = 4, 13%). Patients harbouring SDHB mutations had unilateral late-onset head and neck tumours without evidence of recurrence or malignancy. Conclusion This Belgian series confirms the elevated prevalence of predisposing mutations in patients with head and neck and extra-adrenal paragangliomas, but differs from previous reports by the high frequency of SDHB mutations associated with head and neck paragangliomas without evidence of recurrence or malignancy.Keywords
This publication has 33 references indexed in Scilit:
- Phaeochromocytoma, new genes and screening strategiesClinical Endocrinology, 2006
- Genetic Testing in PheochromocytomaAnnals of the New York Academy of Sciences, 2006
- The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiencyBMC Medical Genetics, 2005
- PhaeochromocytomaThe Lancet, 2005
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsJAMA, 2004
- Germ-Line Mutations in Nonsyndromic PheochromocytomaNew England Journal of Medicine, 2002
- Succinate dehydrogenase and human diseases: new insights into a well-known enzymeEuropean Journal of Human Genetics, 2002
- Germline SDHD mutation in familial phaeochromocytomaThe Lancet, 2001
- Mutations in SDHC cause autosomal dominant paraganglioma, type 3Nature Genetics, 2000
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000